Globe Life Inc. (NYSE:GL) Shares Bought by Schonfeld Strategic Advisors LLC

Schonfeld Strategic Advisors LLC raised its holdings in shares of Globe Life Inc. (NYSE:GL - Free Report) by 62.0% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 10,761 shares of the company's stock after purchasing an additional 4,118 shares during the period. Schonfeld Strategic Advisors LLC's holdings in Globe Life were worth $1,200,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Versant Capital Management Inc increased its holdings in Globe Life by 388.0% during the fourth quarter. Versant Capital Management Inc now owns 244 shares of the company's stock valued at $27,000 after buying an additional 194 shares during the period. Albion Financial Group UT bought a new position in shares of Globe Life in the 4th quarter worth $28,000. Rakuten Securities Inc. bought a new stake in Globe Life during the fourth quarter valued at about $28,000. Avalon Trust Co bought a new position in Globe Life in the fourth quarter worth about $41,000. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Globe Life by 32.7% during the fourth quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company's stock valued at $41,000 after buying an additional 90 shares during the last quarter. Institutional investors own 81.61% of the company's stock.

Analyst Upgrades and Downgrades

GL has been the subject of several recent analyst reports. BMO Capital Markets started coverage on shares of Globe Life in a research note on Thursday, January 23rd. They issued a "market perform" rating and a $114.00 target price for the company. Keefe, Bruyette & Woods increased their price target on Globe Life from $137.00 to $145.00 and gave the company an "outperform" rating in a research note on Wednesday, February 12th. Piper Sandler cut their price objective on shares of Globe Life from $152.00 to $147.00 and set an "overweight" rating on the stock in a report on Friday, May 2nd. Morgan Stanley dropped their target price on shares of Globe Life from $126.00 to $117.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. Finally, JPMorgan Chase & Co. raised their price target on shares of Globe Life from $136.00 to $145.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. Four equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Globe Life presently has an average rating of "Moderate Buy" and an average price target of $137.00.

Insider Transactions at Globe Life

In other news, CEO James Matthew Darden sold 24,890 shares of the firm's stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $121.52, for a total value of $3,024,632.80. Following the transaction, the chief executive officer now directly owns 38,973 shares of the company's stock, valued at approximately $4,735,998.96. This trade represents a 38.97 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Frank M. Svoboda sold 11,000 shares of the business's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $122.31, for a total transaction of $1,345,410.00. Following the transaction, the chief executive officer now owns 18,948 shares in the company, valued at $2,317,529.88. The trade was a 36.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.51% of the company's stock.

Globe Life Stock Performance

GL traded up $0.74 on Friday, reaching $121.97. The stock had a trading volume of 436,110 shares, compared to its average volume of 880,409. The business's 50-day moving average price is $123.62 and its two-hundred day moving average price is $117.13. The company has a market cap of $10.15 billion, a P/E ratio of 10.21 and a beta of 0.56. Globe Life Inc. has a 12-month low of $76.55 and a 12-month high of $133.76. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50.

Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings results on Wednesday, April 30th. The company reported $3.07 earnings per share for the quarter, missing analysts' consensus estimates of $3.24 by ($0.17). Globe Life had a return on equity of 22.32% and a net margin of 18.53%. The business had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.49 billion. During the same period in the previous year, the company posted $2.78 EPS. The business's revenue for the quarter was up 4.5% compared to the same quarter last year. Sell-side analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Thursday, July 3rd will be issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.89%. The ex-dividend date of this dividend is Thursday, July 3rd. Globe Life's payout ratio is 8.79%.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.